Advanced Hepatocellular Carcinoma in A Scottish
Population – Current Experience and the Future

Baxter MA; Peters AL; Graham J

Submit Manuscript

ISSN: 2641-1652

Current Trends in Gastroenterology and Hepatology

Mini Review(ISSN: 2641-1652)

Advanced Hepatocellular Carcinoma in A Scottish Population – Current Experience and the Future

Volume 1 - Issue 3

**Baxter MA^1,2*, Peters AL¹, Graham J^1,3**

Author Information Open or Close
- ¹1Beatson West of Scotland Cancer Centre, Glasgow, UK
- ²University of Dundee, UK
- ³University of Glasgow, UK
*Corresponding author: Dr Mark A Baxter, Department of Medical Oncology, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, UK

Received: August 07, 2018; Published: August 10, 2018

DOI: 10.32474/CTGH.2018.01.000112

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current real-world experience with sorafenib in a Scottish population as well as discuss the evidence behind new potential therapies.

Keywords: Sorafenib; Hepatocellular carcinoma; HCC

Abbreviations: HCC: Hepatocellular Carcinoma; PS: Performance Status; OS: Overall Survival; TACE: Transarterial Chemoembolization; VEGF: Vascular Endothelial Growth Factor; PDGFR: Platelet Derived Growth Factor Receptor; FGFR: Fibroblast Growth Factor Receptor; WoS: West of Scotland

Editorial Manager:

Tammy Matthew

Email:

gastroenterology@lupinepublishers.com

gastro@lupinepublisher.co

Track Your Article

Top Editors

Mark E Smith

Bio chemistry
University of Texas Medical Branch, USA
Lawrence A Presley

Department of Criminal Justice
Liberty University, USA
Thomas W Miller

Department of Psychiatry
University of Kentucky, USA
Gjumrakch Aliev

Department of Medicine
Gally International Biomedical Research & Consulting LLC, USA
Christopher Bryant

Department of Urbanisation and Agricultural
Montreal university, USA
Robert William Frare

Oral & Maxillofacial Pathology
New York University, USA
Rudolph Modesto Navari

Gastroenterology and Hepatology
University of Alabama, UK
Andrew Hague

Department of Medicine
Universities of Bradford, UK
George Gregory Buttigieg

Maltese College of Obstetrics and Gynaecology, Europe
Chen-Hsiung Yeh

Oncology
Circulogene Theranostics, England
Emilio Bucio-Carrillo

Radiation Chemistry
National University of Mexico, USA
Casey J Grenier

Analytical Chemistry
Wentworth Institute of Technology, USA
Hany Atalah

Minimally Invasive Surgery
Mercer University school of Medicine, USA
Abu-Hussein Muhamad

Pediatric Dentistry
University of Athens , Greece